Showing 1 - 10 of 8,068
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of...
Persistent link: https://www.econbiz.de/10005049185
This paper examines aspects of the policy environment and market characteristics of the Swedish pharmaceutical sector, assesses the degree to which Sweden has achieved certain policy goals, and puts forth some key findings and conclusions. Thanks to low mark-ups in the distribution chain and no...
Persistent link: https://www.econbiz.de/10005049187
This paper examines aspects of the policy environment and market characteristics of Slovakia's pharmaceutical sector, and assesses the degree to which Slovakia has achieved certain policy goals. Pharmaceutical expenditure in Slovakia accounts for a higher share of total health expenditure than...
Persistent link: https://www.econbiz.de/10005049192
This paper examines aspects of the policy environment and market characteristics of Mexico's pharmaceutical sector, and assesses the degree to which Mexico has achieved certain policy goals. This paper questions the effectiveness of the maximum price regulation. It notes that retail prices for...
Persistent link: https://www.econbiz.de/10005049202
This paper examines aspects of the policy environment and market characteristics of the Swiss pharmaceutical sector, and assesses the degree to which Switzerland has achieved certain policy goals. In Switzerland, pharmaceutical spending has not been growing faster than health expenditure as a...
Persistent link: https://www.econbiz.de/10005049210
Healthcare systems are nowadays facing several challenges starting from an ageing population to a growing demand for more advanced and better healthcare outcomes. This leads to an increase of healthcare costs as well as a need for change in healthcare systems in terms of better and more...
Persistent link: https://www.econbiz.de/10010862534
To investigate stakeholder involvement by Health Technology Assessment Organisations (HTAOs) in France, Spain, England and Wales, Germany, Sweden, and The Netherlands and to examine whether this involvement depends on (i) the administrative tradition and the relevant conception of the...
Persistent link: https://www.econbiz.de/10010573152
The economic transition was harmful all over, but even more harmful for Romania's social landscape. The total population decreased by both birth rate and emigration and the work force follows this trend, the remaining people get older and demographic perspectives are even worse for the following...
Persistent link: https://www.econbiz.de/10005272638
This paper offers a fresh insight into the performance and reform opportunities of the formal health system of Papua … incorporated into possible institutional re-design/reform of the PNG health system. However it does conclude with a number of …
Persistent link: https://www.econbiz.de/10010860343
of the private initiative in the underserved areas are the main targets of the ‘reform’. …
Persistent link: https://www.econbiz.de/10009493133